IGF2 and familial pancreatic carcinoma: In pancreatic cancer, deregulation of IGF2 has also been shown to be associated with beta-cell tumorigenesis, and pancreatoblastoma is associated with chromosome 11p loss of heterozygosity and IGF2 overexpression [13, 16].